Literature DB >> 7897672

Nucleotide and adenosine metabolism in different cell types of human and rat heart.

Z Kochan1, R T Smolenski, M H Yacoub, A L Seymour.   

Abstract

Evaluation of enzyme activities involved in nucleotide metabolism and adenosine production within different cell types can provide important information on their contribution to the overall metabolism of the heart. The following enzyme activities were determined: adenosine kinase (AK), adenosine deaminase (ADA), S-adenosylhomocysteine hydrolase (SAHH), purine nucleoside phosphorylase (PNP), AMP deaminase (AMPD), membrane 5'nucleotidase (M5'N), AMP specific (AC5'N) and IMP specific (IC5'N) cytosolic 5'nucleotidases in (1) rat heart (n = 5), (2) rat cardiomyocytes obtained by collagenase digestion (n = 5), (3) human heart (n = 6) obtained from explants or papillary muscles collected during heart transplantation or mitral valve replacement, and (4) human umbilical cord endothelial cells in primary culture (n = 4). In the human heart, activities (mumol/min/g wet weight) were as follows: AK (0.14 +/- 0.01), ADA (0.46 +/- 0.03), SAHH (0.001 +/- 0.0003), PNP (0.43 +/- 0.08), AMPD (0.41 +/- 0.05), M5'N (1.75 +/- 0.12), IC5'N (0.21 +/- 0.03) and AC5'N (0.11 +/- 0.02). These enzyme activities were lower than those determined in the rat heart with the exception of AC5'N and IC5'N which were equal. The most prominent difference observed was for AMPD and M5'N which were nine and five-fold more active in the rat heart. Rat cardiomyocyte enzyme activities were comparable to those measured in whole rat heart with the exception of ADA (six-fold lower) and PNP (16-fold lower). Endothelial cell activities were notably different from those in the human heart particularly in the case of SAHH (nine-fold higher) and PNP (16-fold higher).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7897672     DOI: 10.1006/jmcc.1994.1168

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  7 in total

1.  Regulation of ecto-5'-nucleotidase by TNF-alpha in human endothelial cells.

Authors:  Kameljit Kalsi; Charlotte Lawson; Martin Dominguez; Patricia Taylor; Magdi H Yacoub; Ryszard T Smolenski
Journal:  Mol Cell Biochem       Date:  2002-03       Impact factor: 3.396

2.  Hyperthyroidism increases adenosine transport and metabolism in the rat heart.

Authors:  R T Smolenski; M H Yacoub; A M Seymour
Journal:  Mol Cell Biochem       Date:  1995-02-23       Impact factor: 3.396

3.  Mammalian mismatches in nucleotide metabolism: implications for xenotransplantation.

Authors:  Zain Khalpey; Ada H Y Yuen; Marialuisa Lavitrano; Christopher G A McGregor; Kameljit K Kalsi; Magdi H Yacoub; Ryszard T Smolenski
Journal:  Mol Cell Biochem       Date:  2007-07-27       Impact factor: 3.396

4.  AMP-regulated protein kinase activity in the hearts of mice treated with low- or high-fat diet measured using novel LC-MS method.

Authors:  I M Rybakowska; E M Slominska; P Romaszko; M Olkowicz; K Kaletha; R T Smolenski
Journal:  Mol Cell Biochem       Date:  2015-02-25       Impact factor: 3.396

5.  Effect of decaffeinated coffee on function and nucleotide metabolism in kidney.

Authors:  I M Rybakowska; R Milczarek; E M Slominska; R T Smolenski
Journal:  Mol Cell Biochem       Date:  2017-08-02       Impact factor: 3.396

6.  Nucleotide metabolic mismatches in mammalian hearts: implications for transplantation.

Authors:  Z Khalpey; M H Yacoub; R T Smolenski
Journal:  Ann R Coll Surg Engl       Date:  2013-01       Impact factor: 1.951

7.  Adenosine deaminase inhibition suppresses progression of 4T1 murine breast cancer by adenosine receptor-dependent mechanisms.

Authors:  Barbara Kutryb-Zajac; Patrycja Koszalka; Paulina Mierzejewska; Alicja Bulinska; Magdalena A Zabielska; Karolina Brodzik; Aleksandra Skrzypkowska; Lukasz Zelazek; Iwona Pelikant-Malecka; Ewa M Slominska; Ryszard T Smolenski
Journal:  J Cell Mol Med       Date:  2018-10-05       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.